Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance

Topcu, Semra; Tok, Derya; ÇALIŞKAN, MUSTAFA; Özçimen, Ebru; Güllü, Hakan; Uçkuyu, Ayla; Erdogan, Doğan; Zeyneloğlu, Hulusi; Müderrisoglu, İbrahim

doi:10.1111/j.1365-2265.2006.02551.x

Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance

Atıf İçin Kopyala

Topcu S., Tok D., ÇALIŞKAN M. , Özçimen E. E. , Güllü H., Uçkuyu A., et al.

CLINICAL ENDOCRINOLOGY, cilt.65, ss.75-80, 2006 (SCI İndekslerine Giren Dergi)

Cilt numarası: 65 Konu: 1
Basım Tarihi: 2006
Doi Numarası: 10.1111/j.1365-2265.2006.02551.x
Dergi Adı: CLINICAL ENDOCRINOLOGY
Sayfa Sayısı: ss.75-80

Özet

Background Women with polycystic ovary syndrome (PCOS) are thought to have increased cardiovascular risk. Metformin therapy reduces whole-body insulin resistance (IR) in patients with type-2 diabetes mellitus (DM).